Increase allocation of Remdesivir to Maharashtra: HC tells Centre
SECTIONS
Last Updated: May 02, 2021, 05:31 PM IST
Share
Synopsis
The bench said the high court came to know about the reduction in the allocation of Remdesivir to Maharashtra from May 1 to May 9. For the earlier period of ten days, the allocation was 4,30,000 vials, and the same for the next 10 days is 3,74,500. This means a reduction of 60,500 vials of Remdesivir for Maharashtra, the judges said.
PTI
3,188,894.0
The Bombay High Court here on Sunday asked the Central government to increase the supply of Remdesivir injections to Maharashtra observing the current reduction in the allocation of the crucial drug is not consistent with the number of active COVID-19 cases as of May 1. In a special hearing, the bench of Justices SB Shukre and Avinash Gharote heard a bunch of petitions on the shortage of medical oxygen and Remdesivir, which is in high demand for treating COVID-19 patients.
India News: : The Bombay high court here on Sunday asked the Central government to increase the supply of Remdesivir injections to Maharashtra observing the curre
Working to bring down Remdesivir injection rate, says Maharashtra FDA ANI | Updated: Mar 11, 2021 13:30 IST
Mumbai (Maharashtra) [India], March 11 (ANI): The Maharashtra Food and Drugs Administration (FDA) on Thursday said it is working to bring down the cost of the Remdesivir 100 mg injection, used for treating critical COVID-19 patients. The Maharashtra FDA has found that manufacturers are supplying this injection at a cheaper cost of Rs 800- Rs 1300 due to comparatively lesser demands than the initial days. But patients are not getting the benefit of the same cheaper prices. They are forced to purchase the injection at higher costs which are printed as MRP, the FDA said in the statement.